Mode
Text Size
Log in / Sign up
N/A N=6 Randomized Treatment

Video Assisted Speech Technology to Enhance Motor Planning for Speech

Autism Spectrum Disorder · Apraxia of Speech

Enrolled (actual)
6
Serious AEs
0.0%
Results posted
May 2023
Primary outcome: Primary: Change in Mean Length of Utterance (MLU) — 0.5387; 0.2987 Morphemes per utterance — p=<0.555

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Video Assisted Speech Therapy (VAST) (Behavioral)
Age
Pediatric · 4+ yrs
Sex
All
Sponsor
iTherapy, LLC
Primary completion
Nov 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Mean Length of Utterance (MLU)
0.5387; 0.2987 <0.555
PRIMARY
Change in Percentage of Correctly Transcribed Words Using Automatic Speech Recognition
1.388; 0 <0.289
PRIMARY
Change in Articulation Accuracy
19.75; 16.24 0.4296
SECONDARY
Parent Perceptions of Communication Changes, Resulting From Study Participation.
11; 9.67 <0.659
SECONDARY
Change in Type-Token Ratios
30.158; 22.26 <0.789
SECONDARY
Increase in Response Rate to Treatment Stimuli
5.67; 3.33 <0.485

Summary

Nearly 3.5 million Americans are diagnosed with Autistic Spectrum Disorder (ASD), a communication disorder that causes skill limitations in the areas of language acquisition, sensory integration, and behavior. This lack of functional language ability limits conversation to its most basic parts, making daily tasks difficult for minimally to non-verbal individuals to achieve. iTherapy is developing the VAST platform, a personalized educational experience for students with ASD by creating a virtual reality-based video-modeling program to stimulate engagement and speech production practice, ultimately providing those with ASD an opportunity to enhance their quality of life by increasing their speech abilities which will enable them to build social networks and handle the events of daily life.

Eligibility Criteria

Inclusion Criteria

  • Nonverbal-minimally verbal children (0-5 words)
  • Diagnosis of Autism Spectrum Disorder

Exclusion Criteria

  • No history of seizures for participating with VR goggles.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04764539). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search